European Respiratory Review

Article	Citations
Reply to: “Nicotine or tobacco abstinence?”	281
European Respiratory Review, list of peer reviewers 2022	190
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	141
European Respiratory Review, list of peer reviewers 2023	136
Exacerbations of bronchiectasis	128
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	121
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	114
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	114
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	112
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	99
Live teleultrasound for evaluation of the chest: a systematic review	94
The role of telemonitoring in patients on home mechanical ventilation	84
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	81
ERS/EAACI statement on adherence to international adult asthma guidelines	81
The re-emerging role of linoleic acid in paediatric asthma	80
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	78
Global respiratory health priorities at the beginning of the 21st century	73
Lung stem cells and respiratory epithelial chimerism in transplantation	72
Advance care planning in patients with respiratory failure	69
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	68
Air pollution as an early determinant of COPD	66
Inhaled corticosteroids for the treatment of COVID-19	66
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	64
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	64
Epidemiology of severe asthma in children: a systematic review and meta-analysis	64

Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	62
The ageing of people living with cystic fibrosis: what to expect now?	62
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	60
Sarcopenia in interstitial lung disease	60
Sex and gender in interstitial lung diseases	59
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	59
Phenotype overlap in the natural history of asthma	56
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	56
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	55
Smoking cessation and vaccination	54
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	53
Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review	52
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	51
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	48
Methods to assess COPD medications adherence in healthcare databases: a systematic review	46
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications	44
Sex and gender in respiratory physiology	43
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	43
Pathophysiology and genomics of bronchiectasis	43
Nonpharmacological interventions in COPD	43
REM sleep obstructive sleep apnoea	42
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	42
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	42
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	41
Pro: Clinical remission in asthma – implications for asthma management	41
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	41
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	40
Sex and gender in pulmonary arterial hypertension	40
Extreme weather and asthma: a systematic review and meta-analysis	39
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	38
Airway ciliated cells in adult lung homeostasis and COPD	38
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	37
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	37
Interplay between respiratory viruses and cilia in the airways	37
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	37
The persistent inflammation in COPD: is autoimmunity the core mechanism?	36
Bronchiolar disorders in systemic autoimmune rheumatic diseases	36
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	36
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	35
Sex and gender in lung health and disease: more than just Xs and Ys	35
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	34
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	34
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	34
Preclinical models of maternal asthma and progeny outcomes: a scoping review	34
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	34
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	33
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	32
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	32
Does pulmonary rehabilitation address treatable traits? A systematic review	32
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	32

Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
New trends in pulmonary hypertension	31
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	31
Parasitic lung diseases	31
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	30
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	29
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	29
The epithelial era of asthma research: knowledge gaps and future direction for patient care	28
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	28
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	27
The association between alcohol consumption and pulmonary function: a scoping review	27
Recycling plastic: diagnosis and management of plastic bronchitis among adults	27
Bronchiectasis in Asia: a review of current status and challenges	27
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	27
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	27
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	27
Association between air pollution and allergic upper respiratory diseases: a meta-analysis	26
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	26
From treatable traits to GETomics in airway disease: moving towards clinical practice	25
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	25
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	25
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	25
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	25
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	24
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	24
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	24
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	24
Digital twins for chronic lung diseases	24
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	23
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	23
Biologics in severe asthma: the role of real-world evidence from registries	23
Managing an ageing cystic fibrosis population: challenges and priorities	23
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	23
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	23
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	23
Gait differences between COPD and healthy controls: systematic review and meta-analysis	22
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives	22
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	22
Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis	22
Determining the minimum important differences for field walking tests in adults with long–term conditions: a systematic review and meta-analysis	22
Cytokine-targeted therapies for asthma and COPD	22
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review	21
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis	21
The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis	21
Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis	21
Protected characteristics reported in pulmonary rehabilitation: a scoping review	21
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis	20
Antibody-mediated protection against respiratory syncytial virus in children	20
The 2025 European Cystic Fibrosis Society position statement on physical activity assessment in cystic fibrosis	20
Diaphragmatic palsy following lung transplantation	19
Lung transplantation for COPD/pulmonary emphysema	19
Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review	18
The effect of graded exercise therapy on fatigue in people with serious respiratory illness: a systematic review	18
Reporting of pre-existing multiple long-term conditions in physical rehabilitation for long COVID: a scoping review	18
Sex and gender in asthma	18
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach	17
The role of evidence-based medicine in the media: misinformation and the COVID-19 lesson	17
The 6-min walk test as a primary end-point in interstitial lung disease	17
Ventilation in the obese: physiological insights and management	17
Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review	17
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis	17
In vivodetection of pulmonary mucociliary clearance: present challenges and future directions	16
How inhaled corticosteroids target inflammation in COPD	16
Biochemical shunt: where and how?	16
A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome	16
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	16
Forbearance with endobronchial stenting: cognisance before conviction	16
“Strength of association between comorbidities and asthma: a meta-analysis” Paola Rogliani, Rossella Laitano, Josuel Ora, Richard Beasley and Luigino Calzetta.Eur Respir Rev2023; 32: 220202	16
Pulmonary rehabilitation and physical interventions	16
CDK4/6 inhibitors in lung cancer: current practice and future directions	15
Obesity and asthma during pregnancy: a systematic review and meta-analysis	15
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery	15
The flare of care for rare: per aspera ad astra for rare lung diseases!	15
End-point definition and trial design to advance tuberculosis vaccine development	15
Performance-based outcome measures to assess functionality in hospitalised patients with COPD exacerbations: a systematic review of the measurement properties	15
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	14
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	14
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	14
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	14
“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	14

Guidance and standard operating procedures for functional exercise testing in cystic fibrosis	14
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	14
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	14
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	13
The role of vascularity and the fibrovascular interface in interstitial lung diseases	13
Dipeptidyl peptidase-1 inhibitors in bronchiectasis	13
Pulmonary veno-occlusive disease: illustrative cases and literature review	13
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	13
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference	12
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	12
Sex, gender and the pulmonary physiology of exercise	12
“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho.Eur Respir Rev2022; 31: 220178	12
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease	12
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	12
Platelets: a potential role in chronic respiratory diseases?	12
Phage therapy: breathing new tactics into lower respiratory tract infection treatments	12
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	12
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties	12
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection	11
Treating central sleep apnoea in heart failure: is positive airway pressure and adaptive servo-ventilation in particular the gold standard?	11
Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder	11
A beginner's guide to using personalised three-dimensional airway stents	11
Managing respiratory muscle weakness during weaning from invasive ventilation	11
Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top	11
Lung volumes, gas transfer and oscillometry after preterm birth: systematic review and meta-analysis	11
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review	11
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract	11
Particulate matter-induced epigenetic modifications and lung complications	11
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	11
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis	11
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	11
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis	11
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint	10
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians	10
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target	10
Unsupervised home spirometryversussupervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis	10
Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease	10
Respiratory management of acute chest syndrome in children with sickle cell disease	10
Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis	10
Strength of association between comorbidities and asthma: a meta-analysis	10
Thank you from the Chief Editor (2022–2024)	10
A role for club cells in smoking-associated lung adenocarcinoma	9
Air pollution, metabolites and respiratory health across the life-course	9
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review	9
Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis	9
Pulmonary capillary recruitment and distention in mammalian lungs: species similarities	9
Pulmonary aspergillosis: diagnosis and treatment	9
Neutrophilic inflammation in bronchiectasis	9
Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors	9
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices	9
The impact of smoking on lung cancer patients	9
Noncoding RNAs in asthmatic airway smooth muscle cells	8
European Respiratory Review, list of peer reviewers 2024	8
Animal models of silicosis: fishing for new therapeutic targets and treatments	8
Home mechanical ventilation in children: evolving indications in an era of new treatment options	8
Rare genetic interstitial lung diseases: a pictorial essay	8
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	8
Multiple breath washout in primary ciliary dyskinesia: a systematic review of the literature	8
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training	8
Respiratory muscle dysfunction in acute and chronic respiratory failure: how to diagnose and how to treat?	8
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	8
Multidisciplinary management of tracheobronchial injury	8
Con: clinical remission in asthma – not yet there	8
The deadly dance of alveolar macrophages and influenza virus	8
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials	8
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	7
Interstitial pneumonia with autoimmune features: challenges and controversies	7
Obesity, leptin and host defence ofStreptococcus pneumoniae: the case for more human research	7
Surgical and bronchoscopic pulmonary function-improving procedures in lung emphysema	7
Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis	7
“Sex and gender differences during the lung lifespan: unveiling a pivotal impact” P. Tondo, C. Meschi, M. Mantero, G. Scioscia, M. Siciliano, M. Bradicich and G.M. Stella, on behalf of the Italian Res	7
20 years of neuromuscular electrical stimulation in COPD	7
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis	7
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications	7
The world of rare interstitial lung diseases	7
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	7
Occupation and SARS-CoV-2 in Europe: a review	7
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	7
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome	7